Financial Statements — CRAQR
Balance Sheet
(in millions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 |
|---|
| Cash & Equivalents | 0.96 | 1.15 | 1.39 | 0.03 |
| Total Current Assets | 1.13 | 1.28 | 1.44 | 0.03 |
| Total Non-current Assets* | 237.69 | 233.39 | 230.87 | 0.19 |
| Total Assets | 238.82 | 234.67 | 232.31 | 0.21 |
| Accounts Payable | 0.11 | 0.05 | 0.04 | -- |
| Total Current Liabilities | 0.21 | 0.13 | 0.12 | 0.23 |
| Total Non-current Liabilities* | 9.20 | 9.20 | 9.20 | 0.00 |
| Total Liabilities* | 9.41 | 9.33 | 9.32 | 0.23 |
| Retained Earnings | (8.27) | (7.99) | -- | (0.04) |
| Total Stockholder Equity | (8.27) | (7.99) | (7.87) | (0.02) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 |
|---|
| Selling, General & Admin | 0.13 | 0.16 | 0.13 | 0.14 | 0.04 |
| Operating Income | (0.13) | (0.16) | (0.13) | (0.14) | (0.04) |
| Pretax Income* | 1.92 | 2.16 | 2.34 | 0.60 | (0.04) |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 1.92 | 2.16 | 2.34 | 0.60 | (0.04) |
| Basic EPS | -- | -- | -- | -- | (0.01) |
| Diluted EPS | -- | -- | -- | -- | (0.01) |
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 |
|---|
| Operating Cash Flow | (0.13) | (0.06) | (0.24) | (0.15) | -- |
| Investing Cash Flow | -- | -- | 0.00 | (230.00) | -- |
| Financing Cash Flow | -- | 0.00 | 0.00 | 231.52 | 0.03 |
